Core Viewpoint - The company, Henan Siwei Automation Equipment Co., Ltd. (referred to as "Siwei Liekong"), has terminated the planning of a change in control and will resume trading of its shares on January 7, 2026, after a temporary suspension due to the uncertainty surrounding the control change [2][6]. Group 1: Stock Suspension Details - The company's stock was suspended from trading on December 29, 2025, due to the potential change in control involving major shareholders [3]. - The suspension was initiated to ensure fair information disclosure and protect investor interests, as the matter was still under negotiation and uncertain [3][4]. Group 2: Termination of Control Change Planning - The termination of the control change planning was due to a lack of agreement on key terms between the parties involved, despite thorough discussions [5]. - The decision to terminate the planning was made to safeguard the interests of all shareholders, and no party will bear liability for breach of contract [5]. Group 3: Business Operations and Financial Impact - The company confirmed that its business operations remain normal and that the termination of the control change planning will not have a significant adverse impact on its operational performance or financial condition [2][5]. Group 4: Resumption of Trading - The company has applied for the resumption of trading, which is scheduled to take place on January 7, 2026 [6].

Group 1: Company Updates - ChaoYing Electronics has adjusted the investment amount for its AI computing power high-end printed circuit board expansion project from 1.468 billion RMB to 3.315 billion RMB, aiming to meet stronger demand for high-end PCB products and enhance overseas production capabilities [2] - Baihua Pharmaceutical and Siwei Control have both terminated their plans for control change due to a lack of consensus with the transaction parties, with their stocks set to resume trading on January 7, 2026 [3] - Aihui Long has signed a strategic cooperation framework agreement with Brain Machine Star Chain to enhance market expansion and sales of brain-machine interface products through its strong sales channels in emergency, brain disease diagnosis, and pediatrics [10] Group 2: Performance Forecasts - Zhongtai Co. expects a net profit of 420 million to 480 million RMB for 2025, recovering from a loss of 77.96 million RMB in the previous year due to improved operations of its subsidiary [5] - Lier Chemical anticipates a net profit of 460 million to 500 million RMB for 2025, representing a year-on-year growth of 113.62% to 132.19% due to increased demand for its products [5] Group 3: Financing and Restructuring - Zhejiang Xiantong plans to issue A-shares to no more than 35 specific investors, raising up to 1.05 billion RMB for smart manufacturing projects and working capital [7] - Longjing Environmental Protection has received acceptance from the Shanghai Stock Exchange for its securities issuance application, pending further approvals [8] Group 4: Strategic Partnerships - Fushite has signed a strategic cooperation agreement with Jiangxi Copper Group to enhance collaboration in mining equipment maintenance and expand overseas market development [15] - Pro Pharmaceutical has entered into a strategic cooperation framework agreement with Xi'an Xintong Pharmaceutical Research Co., focusing on long-term collaboration in innovative drug research and outsourced production [15] Group 5: Market Activity and Stock Performance - Jia Mei Packaging's stock price increased by 230.48% from December 17, 2025, to January 6, 2026, prompting a temporary suspension for investigation due to significant price volatility [11] - Guosheng Technology's stock experienced a 370.20% increase from October 31, 2025, to January 6, 2026, leading to a suspension for review due to potential irrational market behavior [20]

Group 1 - The core viewpoint of the article is the announcement of the termination of control right change plans by Baohua Pharmaceutical and Siwei Liekong, indicating stability in their operations and financial conditions [3][6][10]. Group 2 - Baohua Pharmaceutical's stock was suspended on December 29, 2025, due to potential control right changes, with a recent market capitalization of 4.707 billion [4][13]. - Prior to suspension, Baohua Pharmaceutical's stock price increased by 6.54% and 5.88% in the two trading days leading up to the announcement [4][13]. - For the first three quarters of 2025, Baohua Pharmaceutical reported revenue of 299 million, a year-on-year increase of 2.74%, and a net profit of 32.67 million, up 36.41% year-on-year [6]. Group 3 - Siwei Liekong's stock was also suspended on December 29, 2025, with a total market capitalization of 10.6 billion [7][9]. - The company stated that the termination of the control right change plan would not have a significant adverse impact on its operational performance and financial status [10].

Company Announcements - Jia Mei Packaging's stock price increased by 230% from December 17, 2025, to January 6, 2026, leading to a suspension for investigation starting January 7, 2026 [2] - Guosheng Technology's stock rose by 370.2% during the same period, prompting a suspension for investigation effective January 7, 2026 [3] - Fenglong Co., Ltd. indicated that it may apply for a suspension if its stock price continues to rise abnormally [4] - Xinfang Pharmaceutical is facing public prosecution for alleged unit bribery [7] - Shengke Communication's second-largest shareholder plans to reduce its stake by no more than 3% [8] - Chip Origin Technology completed the acquisition of Zhudian Semiconductor [9] - Robotech's subsidiary signed a significant contract for automatic optical switch packaging with a Swiss client [10] - Aerospace Changfeng clarified that it does not engage in brain-computer interface or commercial aerospace businesses [12] - Chengjian Development holds 18.91 million shares of Century Space, making it the fourth-largest shareholder [13] - Sanbo Brain Science is not involved in the research, production, or sales of brain-computer interface products [14] - Weisi Medical's new products in the brain-computer interface field are still in the early market cultivation stage [16] - Mairande's products in the brain-computer interface area are also in the research and market cultivation phase [17] - Guankang Technology plans to acquire 100% of Liaojing Electronics, with stock resuming trading [19] - Yahui Long signed a strategic cooperation framework agreement with Brain Machine Star Chain to expand its presence in the brain-computer interface field [20] - China Satellite Communications warned that its stock price is at a historical high and may experience a significant drop [21] - Beidou Star Communication stated that commercial aerospace is just one application scenario for its products and services [22] Financial Performance - Lier Chemical expects a net profit increase of 113.62% to 132.19% for 2025 [39] - Zhongtai Co., Ltd. anticipates a net profit of 420 million to 480 million yuan for 2025, recovering from a previous loss [38] Financing and Capital Increase - Desai Xiwai is planning to issue H-shares and list on the Hong Kong Stock Exchange [40] - Xingye Yinx is also preparing to issue H-shares for listing on the Hong Kong Stock Exchange [41] Other Significant Events - Baotailong's controlling shareholder was ordered to rectify its failure to fulfill a shareholding increase commitment [42] - *ST Changyao's stock may face termination of listing due to negative net assets and other financial issues [43]

Group 1 - Baihua Pharmaceutical announced the termination of its control rights change plan due to the lack of consensus among major stakeholders [1][3] - The company's stock was suspended from trading on December 29, 2025, after a significant increase in share price of 6.54% and 5.88% in the two trading days prior to suspension, with a total market value of 4.707 billion yuan [1][3] - For the first three quarters of 2025, Baihua Pharmaceutical reported revenue of 299 million yuan, a year-on-year increase of 2.74%, and a net profit of 32.67 million yuan, up 36.41% year-on-year [3] Group 2 - Siwei Liekong also announced the termination of its control rights change plan after failing to reach an agreement on key terms with the transaction counterparties [4][6] - The company's stock was suspended from trading on December 29, 2025, with a stable price trend prior to suspension and a total market value of 10.6 billion yuan [4][6] - Siwei Liekong stated that the termination of the control rights change plan would not have a significant adverse impact on its business performance and financial status [6]

证券日报网讯 1月6日，思维列控（603508）在互动平台回答投资者提问时表示，经公司向上海证券交 易所申请，公司股票将于2026年1月7日（星期三）开市起复牌。 ...

Macro Dynamics - China has discovered 1,444.49 tons of gold, with plans for a new round of mineral exploration starting in 2026, aiming to enhance the exploration and development of strategic mineral resources [2] - The Ministry of Commerce emphasizes the need for a collaborative approach among government, enterprises, and consumers to promote green consumption policies effectively [3] - The 2026 National Civil Aviation Work Conference highlighted the progress in domestic aircraft development, including the certification of new models and international market expansion [4] Financial Institutions - Bank of America predicts that AI chip stocks will continue to rise, with Nvidia, Broadcom, and AMD identified as top picks as the global semiconductor market is expected to exceed $1 trillion, with a projected 30% year-on-year sales growth in 2026 [7] Market Data - The Shanghai Composite Index reached a ten-year high with a 1.5% increase, and the total trading volume in the Shanghai and Shenzhen markets exceeded 2.8 trillion yuan, marking a significant increase in market activity [8] - As of January 5, the financing balance on the Shanghai Stock Exchange was reported at 1,277.036 billion yuan, reflecting an increase of 8.24 billion yuan from the previous trading day [9] - The Hong Kong Hang Seng Index rose by 1.38%, with significant gains in the brokerage and metals sectors [10] Company Dynamics - WuXi AppTec announced that shareholders controlled by the actual controller have reduced their holdings by 59.6751 million shares, accounting for 2% of the total share capital [12] - Jia Mei Packaging's stock surged by 230% from December 17, 2025, to January 6, 2026, leading to a temporary suspension for price verification [13] - Samsung Electronics is expected to see a 160% year-on-year increase in operating profit for Q4 2025, driven by a surge in demand for storage chips due to the AI boom [14] - Alibaba's AI model for early pancreatic cancer screening has successfully identified cases that may have been missed, showcasing the potential of AI in healthcare [18] - Aerospace company Hangtian Huanyu anticipates that its commercial space revenue will account for less than 15% of total revenue in 2025, with a slight net profit growth of 0.56% year-on-year [19]

智通財經APP訊，思維列控(603508.SH)發佈公告，公司控股股東、實際控制人李欣先生、郭潔女士、 王衛平先生終止籌劃控制權變更的重大事項。公司股票將於2026年1月7日開市起復牌。目前，公司各項 業務經營情況正常，終止籌劃本次控制權變更事項不會對公司經營業績和財務狀況產生重大不利影響。 ...

Core Viewpoint - The company, Siwei Control (603508), announced the termination of a significant control change plan involving its major shareholders due to a lack of consensus on key terms, leading to the resumption of its stock trading on January 7 [1] Group 1 - The major shareholders, Li Xin, Guo Jie, and Wang Weiping, decided to terminate the control change plan after careful consideration and negotiation [1] - The termination of the control change plan will not have a significant adverse impact on the company's operational performance and financial status [1] - The company confirmed that its business operations remain normal despite the termination of the control change plan [1]

证券代码：603508 证券简称：思维列控 公告编号：2026-002 河南思维自动化设备股份有限公司 关于终止筹划控制权变更事项暨复牌的公告 证券停复牌情况：适用 因河南思维自动化设备股份有限公司（以下简称"思维列控"或"公司"） 控股股东、实际控制人李欣先生、郭洁女士、王卫平先生终止筹划控制权变更的 重大事项,本公司的相关证券停复牌情况如下： | 证券代码 | 证券简称 | 停复牌类型 | | 停牌起始日 | 停牌期间 | 停牌终止日 | 复牌日 | | --- | --- | --- | --- | --- | --- | --- | --- | | 603508 | 思维列控 | A 股 | 复牌 | | | 2026/1/6 | 2026/1/7 | 目前公司各项业务经营情况正常，终止筹划本次控制权变更事项不会对公司 经营业绩和财务状况产生重大不利影响。敬请广大投资者理性投资，注意投 资风险。 一、公司股票停牌情况 公司于 2025 年 12 月 28 日收到公司控股股东、实际控制人李欣先生、郭洁女 士、王卫平先生的通知，其正在筹划重大事项，该事项可能导致公司控制权发生 变更。 鉴于该事项仍处于洽谈 ...